Ocena ekspresji Fas i FasL na limfocytach krwi obwodowej chorych na raka krtani

Journal of Electrocardiology - J ELECTROCARDIOL 01/2011; 65(3):33-38. DOI: 10.1016/S0030-6657(11)70651-5

ABSTRACT The aim of the study was evaluation of Fas and FasL receptors’ expression on peripheral blood lymphocytes in patients with laryngeal cancer. The study was conducted in a group of 62 patients with different clinical stages of the disease. The study material consisted of the peripheral blood obtained from the studied population, from which T lymphocytes were isolated and incubated with monoclonal antibodies. To evaluate antigens’ expression, a FACS Galibur flow cytometre was used. The flow cytometry evaluated cells were labeled with fluorochrome-conjugated monoclonal antibodies. Obtained results were compared with the measurements taken in 20 healthy individuals who constituted the control group. In the conducted study a significant decrease in the Fas and FasL receptors’ expression on CD+ lymphocytes was found in comparison with the expression of these proteins observed in the control group. Moreover, a higher level of Fas expression was observed on the peripheral blood lymphocytes of patients with stage I clinical advancement of laryngeal cancer in comparison with those who had more advanced stages of the disease (Groups II, III, IV), which may be indicative of higher activation and susceptibility of peripheral blood lymphocytes to apoptosis in patients with the early stage of the disease.
A negative (reverse) correlation was also found between Fas and FasL receptors’ expression and the organ advancement of laryngeal cancer, which may provide further evidence that together with the progress of the disease the susceptibility of peripheral blood lymphocytes to apoptosis decreases.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Fas is a 45-kD cell surface protein belonging to the tumor necrosis factor/nerve growth factor receptor family, and transduces the signal for apoptosis. The cytotoxic T lymphocyte (CTL) hybridoma, PC60-d10S requires the presence of Fas on target cells to induce cytolysis in target cells. This CTL cell line was weakly but specifically stained by a chimeric protein that consisted of the extracellular domain of mouse Fas and the Fc portion of human immunoglobulin G1 (mFas-Fc). Moreover, mFas-Fc inhibited the cytotoxic activity of PC60-d10S. Sublines of d10S that were stained intensively by mFas-Fc were isolated by repetitive fluorescence-activated cell sorter sorting. A cell-surface protein of about 40 kD was specifically precipitated by mFas-Fc from the lysates of these sublines. This protein was homogeneously purified by sequential affinity chromatographies using mFas-Fc and concanavalin A beads. The purified protein exhibited cytotoxic activity against cells expressing Fas but not to the cells which do not express Fas. These results indicated that the 40-kD membrane glycoprotein expressed on PC60-d10S cells is the Fas-ligand that induces the apoptotic signal by binding to Fas.
    Journal of Experimental Medicine 04/1994; 179(3):873-9. · 13.21 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Fas is an apoptosis-signaling receptor molecule on the surface of a number of cell types. Molecular cloning and nucleotide sequence analysis revealed a human Fas messenger RNA variant capable of encoding a soluble Fas molecule lacking the transmembrane domain because of the deletion of an exon encoding this region. The expression of soluble Fas was confirmed by flow cytometry and immunocytochemical analysis. Supernatants from cells transfected with the variant messenger RNA blocked apoptosis induced by the antibody to Fas. Levels of soluble Fas were elevated in patients with systemic lupus erythematosus, and mice injected with soluble Fas displayed autoimmune features.
    Science 04/1994; 263(5154):1759-62. · 31.03 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Fas ligand (FasL), a cell surface molecule belonging to the tumor necrosis factor family, binds to its receptor Fas, thus inducing apoptosis of Fas-bearing cells. Various cells express Fas, whereas FasL is expressed predominantly in activated T cells. In the immune system, Fas and FasL are involved in down-regulation of immune reactions as well as in T cell-mediated cytotoxicity. Malfunction of the Fas system causes lymphoproliferative disorders and accelerates autoimmune diseases, whereas its exacerbation may cause tissue destruction.
    Science 04/1995; 267(5203):1449-56. · 31.03 Impact Factor


Available from